Healthcare provider profile · identity verified

Rachel Lynn Smith

Nurse Practitioner · SAGINAW, MI · NPI 1790307445

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	305	30
Amlodipine Besylate	Amlodipine Besylate	297	22
Tamsulosin Hcl	Tamsulosin Hcl	264	16
Duloxetine Hcl	Duloxetine Hcl	247	suppressed
Simvastatin	Simvastatin	245	15
Pantoprazole Sodium	Pantoprazole Sodium	229	18
Potassium Chloride	Potassium Chloride	228	18
Omeprazole	Omeprazole	223	15
Buspirone Hcl	Buspirone Hcl	193	12
Sertraline Hcl	Sertraline Hcl	193	15
Metoprolol Succinate	Metoprolol Succinate	188	13
Levothyroxine Sodium	Levothyroxine Sodium	181	18
Lisinopril	Lisinopril	177	11
Donepezil Hcl	Donepezil Hcl	172	suppressed
Gabapentin	Gabapentin	151	15
Metoprolol Tartrate	Metoprolol Tartrate	146	13
Furosemide	Furosemide	125	suppressed
Carvedilol	Carvedilol	124	suppressed
Metformin Hcl	Metformin Hcl	122	14
Trazodone Hcl	Trazodone Hcl	117	suppressed
Allopurinol	Allopurinol	114	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	110	suppressed
Clopidogrel	Clopidogrel Bisulfate	104	13
Eliquis	Apixaban	103	suppressed
Losartan Potassium	Losartan Potassium	97	suppressed
Famotidine	Famotidine	96	suppressed
Pregabalin	Pregabalin	83	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	12
Pravastatin Sodium	Pravastatin Sodium	74	suppressed
Divalproex Sodium Er	Divalproex Sodium	73	suppressed
Risperidone	Risperidone	73	suppressed
Clonazepam	Clonazepam	71	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	71	suppressed
Jardiance	Empagliflozin	66	suppressed
Meloxicam	Meloxicam	66	suppressed
Divalproex Sodium	Divalproex Sodium	61	suppressed
Lorazepam	Lorazepam	61	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Hydralazine Hcl	Hydralazine Hcl	59	suppressed
Tramadol Hcl	Tramadol Hcl	59	suppressed
Alendronate Sodium	Alendronate Sodium	56	suppressed
Bethanechol Chloride	Bethanechol Chloride	53	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Dantrolene Sodium	Dantrolene Sodium	51	suppressed
Cilostazol	Cilostazol	50	suppressed
Cyclobenzaprine Hcl Er	Cyclobenzaprine Hcl	50	suppressed
Dapagliflozin	Dapagliflozin Propanediol	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	25
Escitalopram Oxalate	Escitalopram Oxalate	48	suppressed
Ibuprofen	Ibuprofen	48	suppressed
Januvia	Sitagliptin Phosphate	48	suppressed
Lamotrigine	Lamotrigine	48	suppressed
Montelukast Sodium	Montelukast Sodium	48	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	46	13
Solifenacin Succinate	Solifenacin Succinate	45	suppressed
Colestipol Hcl	Colestipol Hcl	43	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	43	suppressed
Trintellix	Vortioxetine Hydrobromide	41	suppressed
Bumetanide	Bumetanide	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Aripiprazole	Aripiprazole	39	suppressed
Rexulti	Brexpiprazole	39	suppressed
Anastrozole	Anastrozole	38	suppressed
Benztropine Mesylate	Benztropine Mesylate	38	suppressed
Glimepiride	Glimepiride	38	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	37	suppressed
Levetiracetam	Levetiracetam	37	suppressed
Baclofen	Baclofen	36	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Cephalexin	Cephalexin	35	19
Metformin Hcl Er	Metformin Hcl	35	suppressed
Finasteride	Finasteride	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Latanoprost	Latanoprost	27	suppressed
Metformin Er Osmotic	Metformin Hcl	26	suppressed
Tiotropium Bromide	Tiotropium Bromide	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Buprenorphine	Buprenorphine	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Metaxalone	Metaxalone	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Olanzapine	Olanzapine	15	suppressed
Primidone	Primidone	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Prednisone	Prednisone	14	suppressed
Atenolol	Atenolol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Levetiracetam Er	Levetiracetam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Silodosin	Silodosin	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error